LEXX Lexaria Bioscience Corp Accounting Capitalization

This daily price chart for Lexaria Bioscience (LEXX) on the GURU.Markets platform shows quotes currently trading at 0.01. The business relies on the automation of compound synthesis in laboratories to ensure flawless reaction control. The innovative DehydraTECH method enables the conversion of injectable forms into tablets, improving substance absorption. Stable management has earned industry recognition for the effective licensing of its developments.

Book value represents the sum of net assets minus total liabilities, determining the real intrinsic value of the business and the level of capital protection. By analyzing the volatility of book value, an investor assesses the financial stability of Lexaria Bioscience (LEXX), which optimizes costs through production outsourcing in the US while maintaining a focus on developing its own DehydraTECH laboratories in Canada.